Treating hearts and minds: adverse cardiovascular effects of psychiatric medications
Therapeutic Advances in Drug Safety
Published online on March 29, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Cardiovascular disease (CVD) is one of the leading causes of death in patients with severe mental illness (SMI), being ~3.3 times higher than in the general population. The adverse cardiovascular effects of psychiatric medications have short- and long-...
Cardiovascular disease (CVD) is one of the leading causes of death in patients with severe mental illness (SMI), being ~3.3 times higher than in the general population. The adverse cardiovascular effects of psychiatric medications have short- and long-...